C
Colinz Laboratories Ltd
BSE:531210
Colinz Laboratories Ltd
BSE:531210
Price:
44.01
INR
-2.85%
Market Cap:
₹110.9m
Cash Flow Statement
Cash Flow Statement
Colinz Laboratories Ltd
Colinz Laboratories Ltd
Currency: INR
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
2
|
2
|
2
|
3
|
5
|
5
|
6
|
6
|
7
|
7
|
6
|
6
|
|
| Depreciation & Amortization |
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
|
| Cash Taxes Paid |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Cash Interest Paid |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
3
|
16
|
18
|
9
|
(1)
|
(3)
|
(2)
|
(1)
|
5
|
8
|
(20)
|
(11)
|
|
| Cash from Operating Activities |
6
N/A
|
19
+220%
|
22
+16%
|
14
-36%
|
5
-66%
|
4
-24%
|
4
+14%
|
5
+18%
|
10
+117%
|
14
+39%
|
(15)
N/A
|
(7)
+51%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(0)
|
0
|
(2)
|
(2)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-5%
|
(2)
-292%
|
(2)
+2%
|
(0)
+79%
|
(0)
+6%
|
0
N/A
|
0
+10%
|
0
-28%
|
0
+12%
|
(2)
N/A
|
(2)
+1%
|
|
| Financing Cash Flow | |||||||||||||
| Other |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
2
|
3
|
|
| Cash from Financing Activities |
1
N/A
|
1
+62%
|
1
-20%
|
1
-31%
|
1
+63%
|
1
+31%
|
1
-6%
|
2
+37%
|
2
+51%
|
3
+9%
|
2
-5%
|
3
+35%
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
6
N/A
|
19
+217%
|
21
+9%
|
13
-38%
|
5
-59%
|
4
-16%
|
5
+19%
|
6
+22%
|
13
+99%
|
17
+33%
|
(15)
N/A
|
(6)
+57%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
5
N/A
|
19
+246%
|
20
+8%
|
12
-39%
|
4
-65%
|
3
-27%
|
4
+28%
|
5
+18%
|
10
+117%
|
14
+39%
|
(17)
N/A
|
(10)
+43%
|
|
Switch to:
Switch to:
See Also
Discover More
